Despite being off-patent for many years, Humalog and other insulin brands continue to make high sales, with Lilly booking around $3 billion from its product last year, $1.8 billion of which was ...

Sanofi’s Admelog (insulin lispro) is approved in type 1 and type 2 diabetes as a follow-on drug to Humalog, a rapid-acting insulin that is Lilly’s top selling drug, bringing in almost $700 ...

NovoLog (insulin aspart) is a fast-acting insulin used for diabetes treatment. It’s injected 5 to 10 minutes before meals. It may be prescribed with other insulins or oral diabetes drugs.

The insulin pens market is witnessing significant growth due to the increasing prevalence of diabetes worldwide and the rising preference for advanced, user-friendly insulin delivery systems. Insulin ...

The United States insulin pen market size was valued at USD 4.2 billion in 2024 and is projected to hit around USD 8.1 billion by 2033, growing at a CAGR of 6.9% during the forecast period 2025 to ...

The U.S. insulin pen market is set to grow from USD 4.2 billion in 2024 to USD 8.1 billion by 2033 at a 6.9% CAGR. Key growth drivers include advanced technology, increased awareness, and favorable ...

The cost of a prescription for generic Humalog ranges between $44 and close to $100 on the website GoodRx. Lilly also is launching in April a biosimilar insulin to compete with Sanofi's Lantus.

CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...

Patients were randomly assigned (1:1) to receive their insulin using pen devices or vials and syringes. The study was conducted in accordance with the Declaration of Helsinki. [16] ...

Administration of insulin through pen devices in the ambulatory care setting has been shown to improve insulin regimen adherence and patient satisfaction. [5–9] Authors of a survey evaluating ...

This March 1, 2023, photo shows a vial of Eli Lilly's Humalog insulin in New York. (AP Photo/Pablo Salinas) LOS ANGELES (CN) — A Superior Court judge, on Tuesday, told lawyers for the state of ...

CDSCO allows Lilly to launch weight-loss drug Mounjaro in pen format The KwikPen is a multi-dose, single-patient-use prefilled pen designed for once-in-a week administration ...